# Registry of Patients Treated With Systemic Mold-Active Triazoles

> **NCT03066011** · — · COMPLETED · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 2015 (actual)

## Conditions studied

- Invasive Fungal Infection

## Interventions

- **DRUG:** Isavuconazonium sulfate
- **DRUG:** Voriconazole
- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT03066011
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-16
- **Primary completion:** 2020-04-24
- **Final completion:** 2020-04-24
- **Target enrollment:** 2015 (ACTUAL)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03066011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03066011, "Registry of Patients Treated With Systemic Mold-Active Triazoles". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03066011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*